Steven Cohen Eli Lilly & CO Call Options Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $3.09 Million - $3.63 Million	11,100 New	11,100 $3.6 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $35.7 Million - $44.2 Million	-300,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $32.1 Million - $39.7 Million	300,000 New	300,000 $39.4 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.